PROLIFICA - West African Treatment Cohort for Hepatitis B

CompletedOBSERVATIONAL
Enrollment

1,079

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Hepatitis B, ChronicHepatocellular Carcinoma
Interventions
DRUG

Tenofovir disoproxil

Tenofovir disoproxil 245 mg once daily

Trial Locations (2)

Unknown

UFR Sante Thies,, Thiès

MRC Laboratories Hospital, Fajara

All Listed Sponsors
collaborator

Medical Research Council Unit, The Gambia

OTHER

collaborator

Department of State for Health and Social Welfare, The Gambia

OTHER_GOV

collaborator

UFR Sante de Thies, Senegal

UNKNOWN

collaborator

Cheikh Anta Diop University, Senegal

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

International Agency for Research on Cancer

OTHER

lead

Imperial College London

OTHER

NCT02129829 - PROLIFICA - West African Treatment Cohort for Hepatitis B | Biotech Hunter | Biotech Hunter